Sandbox 1666
From Proteopedia
(Difference between revisions)
(4 intermediate revisions not shown.) | |||
Line 22: | Line 22: | ||
<scene name='88/880343/Space_filling_view/1'>Here</scene> is a space fill of CTX-M Beta-Lactamase, which shows where the interactions are in between each domain and where the active sites are located. | <scene name='88/880343/Space_filling_view/1'>Here</scene> is a space fill of CTX-M Beta-Lactamase, which shows where the interactions are in between each domain and where the active sites are located. | ||
- | <scene name='88/880343/ | + | <scene name='88/880343/Hydrophobic-polar_view/2'>Here</scene> is a view of hydrophobic/polar interactions that are within domain A of the enzyme. |
== Other Important Features == | == Other Important Features == | ||
Line 29: | Line 29: | ||
== References == | == References == | ||
- | + | Soeung V, Lu S, Hu L, Judge A, Sankaran B, Prasad BVV, Palzkill T. A drug-resistant β-lactamase variant changes the conformation of its active-site proton shuttle to alter substrate specificity and inhibitor potency. J Biol Chem. 2020 Dec 25;295(52):18239-18255. doi: 10.1074/jbc.RA120.016103. Epub 2020 Oct 26. PMID: 33109613. |
Current revision
CTX-M Beta-Lactamase
CTX-M Beta Lactamase is a class a enzyme. This enzyme creates drug resistance to ampicillin and cefotaxime through a two step process: deacylation and acylation.
|
References
Soeung V, Lu S, Hu L, Judge A, Sankaran B, Prasad BVV, Palzkill T. A drug-resistant β-lactamase variant changes the conformation of its active-site proton shuttle to alter substrate specificity and inhibitor potency. J Biol Chem. 2020 Dec 25;295(52):18239-18255. doi: 10.1074/jbc.RA120.016103. Epub 2020 Oct 26. PMID: 33109613.